Ikarian Capital’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.65M | Buy |
100,000
+50,000
| +100% | +$1.33M | 0.51% | 34 |
|
|
2025
Q1 | $1.21M | Buy |
+50,000
| New | +$1.21M | 0.15% | 56 |
|
|
2024
Q3 | – | Sell |
-138,262
| Closed | -$7.33M | – | 128 |
|
|
2024
Q2 | $7.33M | Buy |
+138,262
| New | +$7.33M | 1.28% | 13 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 117 |
|
|
2023
Q2 | – | Sell |
-43,156
| Closed | -$719K | – | 115 |
|
|
2023
Q1 | $719K | Sell |
43,156
-160,000
| -79% | -$2.66M | 0.16% | 63 |
|
|
2022
Q4 | $1.91M | Sell |
203,156
-260,000
| -56% | -$2.44M | 0.46% | 30 |
|
|
2022
Q3 | $1.26M | Sell |
463,156
-372,119
| -45% | -$1.01M | 0.25% | 33 |
|
|
2022
Q2 | $2.41M | Buy |
835,275
+302,846
| +57% | +$875K | 0.44% | 26 |
|
|
2022
Q1 | $1.6M | Buy |
532,429
+31,787
| +6% | +$95.3K | 0.21% | 48 |
|
|
2021
Q4 | $2.3M | Hold |
500,642
| – | – | 0.34% | 35 |
|
|
2021
Q3 | $3.14M | Sell |
500,642
-24,112
| -5% | -$151K | 0.22% | 49 |
|
|
2021
Q2 | $3.14M | Sell |
524,754
-200,000
| -28% | -$1.2M | 0.25% | 52 |
|
|
2021
Q1 | $4.58M | Buy |
+724,754
| New | +$4.58M | 0.15% | 46 |
|
|
2020
Q3 | – | Sell |
-1,159
| Closed | -$8K | – | 149 |
|
|
2020
Q2 | $8K | Sell |
1,159
-125,000
| -99% | -$863K | ﹤0.01% | 87 |
|
|
2020
Q1 | $590K | Hold |
126,159
| – | – | 0.04% | 59 |
|
|
2019
Q4 | $1.01M | Buy |
+126,159
| New | +$1.01M | 0.16% | 29 |
|